The Next Generation Sequencing (NGS) Market is projected to reach $27.5 billion by 2030, with a compound annual growth rate (CAGR) of 15.8% during the forecast period, according to Meticulous Research®. NGS is a cutting-edge technology for sequencing nucleotides in genetic material, allowing for quicker and more cost-effective DNA and RNA sequencing compared to traditional Sanger sequencing. Key drivers of the NGS market include advancements in sequencing technologies, increased genome mapping initiatives, growing drug discovery platforms requiring NGS, and decreasing genome sequencing costs.

Top 10 Companies in the Next Generation Sequencing Market
Illumina, Inc. (U.S.)
Established in 1998 and headquartered in California, Illumina offers sequencing and array-based solutions for genomic and genetic analysis through its Core Illumina and GRAIL segments. The company serves government labs, research centers, academic institutions, hospitals, commercial diagnostics labs, and pharmaceutical companies globally, with facilities in the U.S., Singapore, and the U.K., and subsidiaries in Germany, Australia, the U.K., Italy, the Netherlands, and Japan.

Thermo Fisher Scientific, Inc. (U.S.)
Founded in 1956 and based in Massachusetts, Thermo Fisher provides products and services across multiple sectors, including pharmaceuticals and healthcare. Its Life Sciences Solutions segment offers NGS products like the Ion GeneStudio S5 System and Ion Torrent Genexus System. Thermo Fisher has a robust global presence, with a workforce of 130,000 and subsidiaries in the U.S., U.K., and France, among others.

Beijing Genomics Institute (BGI) (China)
Established in 1999 in Shenzhen, China, BGI provides proteomics and genomics sequencing services worldwide. The company uses the DNBSEQ NGS platform for most of its sequencing solutions and operates offices in Denmark, the U.S., China, and Japan, employing around 6,000 people.

Qiagen N.V. (Netherlands)
Founded in 1984 and headquartered in Venlo, Qiagen offers sample and assay technologies for molecular diagnostics and research. The company’s NGS offerings include diagnostic solutions, PCR products, and sequencing services. Qiagen operates in over 130 countries, with facilities in the U.S., China, Germany, and other nations, and has a strong sales and distribution network.

Hoffmann-La Roche Ltd (Switzerland)
Established in 1896 and based in Basel, Roche operates through its Pharmaceuticals and Diagnostics divisions. The Diagnostics division offers NGS products and other diagnostic solutions. Roche has a significant global presence with facilities in the U.S., Germany, Switzerland, Japan, China, and other countries, and numerous subsidiaries worldwide.
Download Free Sample Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5040

PerkinElmer, Inc. (U.S.)
Founded in 1937 and headquartered in Massachusetts, PerkinElmer provides products and services for the life sciences and diagnostics markets. The company’s Diagnostics segment includes NGS offerings, with manufacturing and R&D facilities in the U.S., China, Japan, and Germany, and a presence in over 190 countries.

Agilent Technologies, Inc. (U.S.)
Established in 1999 and headquartered in California, Agilent provides solutions for life sciences, diagnostics, and applied chemical markets. The company’s Diagnostics and Genomics segment includes NGS products. Agilent operates globally, with research and manufacturing sites in the U.S., China, Germany, and other countries.

Pacific Biosciences of California, Inc. (U.S.)
Incorporated in 2004 and based in California, Pacific Biosciences develops sequencing solutions for complex genetic research. The company offers HiFi long-read and short-read sequencing technologies and serves various research institutions and commercial labs. Pacific Biosciences has a presence in the U.K., China, Japan, and other regions.

Danaher Corporation (U.S.)
Founded in 1984 and headquartered in Washington, D.C., Danaher designs and markets products for various industries. Its Life Sciences segment includes NGS products, with a significant global footprint and subsidiaries like Beckman Coulter and Integrated DNA Technologies in the U.S.

Oxford Nanopore Technologies Plc. (U.K.)
Founded in 2005 and headquartered in England, Oxford Nanopore manufactures devices for real-time DNA and RNA sequencing. The company’s products are used in various research applications and it operates in more than 120 countries, serving universities, labs, and research institutions.

Market Insights
According to Meticulous Research®, the NGS market is expected to grow significantly, driven by technological advancements and the increasing adoption of NGS in various scientific and medical fields. The global reach and diverse applications of NGS technology highlight its importance in the future of genomic research and diagnostics.
Find Top 10 Companies here: https://meticulousblog.org/top-10-companies-in-next-generation-sequencing-market/